Search

everythinglearnresearchcommunity

for

Search:↓

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The document explains various skin conditions in cats and how to diagnose and treat them.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Exosomes could be effective for improving skin health and treating skin diseases.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Male gender and family history predict alopecia areata recurrence.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Acne is a temporary skin imbalance during puberty that often resolves on its own.